The Growing Awareness & Concern About Hormone Replacement Therapy with Dr. Mansoor Mohammed

In this episode we speak with Dr. Mansoor Mohammed about the growing awareness & concern about hormone replacement therapy. Dr. Mansoor is the President and COO of The DNA Company, a leading and innovative provider of comprehensive Functional Genomics testing and consulting and an industry first: Individually customized supplements. He is widely regarded as a pioneer in medical genomics and has been the recipient of multiple academic and industry awards. He is the holder of several patents in the general fields of molecular diagnostics and genomics research and is one of the most sought-after national and international conference speakers in the genre of personalized medicine. Prior to his role at The DNA Company, Dr. Mansoor was: • Founder and President of ManaGene (2010-2018) • CEO of Combimatrix (Nasdaq traded leader in diagnostic genomic microarrays) (2006-2010) • Director of Genomics at Quest Diagnostics (The world’s largest reference laboratory with a market capitalization of over $10 billion US) (2003-2006) • Director of Research and Development at Spectral Genomics (one of the industry’s first commercial genomic microarray developers spun out of Baylor College of Medicine under Dr. Mansoor’s scientific leadership) Dr. Mansoor maintains an active clinical practice as a genomics consultant to some of the leading executive health clinics in Canada and abroad. Learning Points: • Pollution & baldness • What is the most recent research telling us about Hormone Replacement Therapy? • Is there a place for Hormone Replacement Therapy in women’s health? • How can women improve breast health? Social Media: www.thednacompany.com